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The high potency and selectivity of various peptide neurotoxins within spider 
venoms means these toxins are being considered as leads for the 
development of new environmentally-benign biopesticides that target pest 
insects. Currently, the -HXTX family of 37-residue arthropod-selective 
peptide neurotoxins from Australian hexathelid spider venoms are considered 
a prime candidate for biopesticide development. -HXTX-Hv1a, a prototypic 
member of the -HXTX-1 family, was electrophysiologically characterised by 
voltage-clamp analysis using the whole-cell patch-clamp technique on 
cockroach dorsal unpaired median (DUM) neurons. -HXTX-Hv1a exerted a 
reversible, concentration-dependent, voltage-independent block of barium 
currents (IBa) through mid-low voltage-activated (M-LVA) and high voltage-
activated (HVA) voltage-activated calcium (Cav) channels without alteration in 
the activation or inactivation kinetics of the Cav channel. To improve the 
structural stability of this disulfide-rich peptide under biologically reducing 
conditions, and thereby increase its commercial viability, a synthetic -HXTX-
Hv1a mutant was produced with the replacement of one disulfide bond with a 
Sec1,4 diselenide bridge. The selenocysteine mutant had comparable oral 
activity to the native toxin in blowflies and there was no significant difference 
between the native and diselenide toxin in terms of block of M-LVA and HVA 
CaV channels. This demonstrated that selenocysteine substitution had the 
potential to improve peptide stability without altering the biological activity of 
the toxin.   
 
There is a continuous need to identify novel insecticidal peptide toxins for 
biopesticide development. By screening the venom of mygalomorph Sydney 
funnel-web (Atrax robustus) and Eastern mouse (Missulena bradleyi) spiders; 
two novel insect-selective peptide neurotoxins were isolated: -HXTX-Ar1a 
from A. robustus is a homolog of -HXTX-Hv1a, and -AOTX-Mb1a from M. 
bradleyi has up to 59% homology with the -HXTX family. In acute toxicity 
tests in house crickets, these neurotoxins induced potent neuroexcitatory 
symptoms followed by paralysis and death. Vertebrate nerve-muscle 
preparations showed that the toxins lacked overt vertebrate toxicity at 
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concentrations up to 1 M. To further characterise the molecular target of -
HXTX-Ar1a and -AOTX-Mb1a on insects, whole-cell patch-clamp 
experiments were undertaken on cockroach DUM neurons. -HXTX-Ar1a 
induced a reversible, and the -AOTX-Mb1a an irreversible, block of both M-
LVA and HVA Cav channels. The level of block was concentration-dependent 
and occurred in the absence of alterations in the voltage-dependence of Cav 
channel activation. The block was voltage-independent, suggesting that these 
toxins are Cav channel pore blockers rather than channel gating modifiers. 
Both -HXTX-Ar1a and -AOTX-Mb1a are promising biopesticide candidates 
and their activity on M-LVA and HVA Cav channels validates insect Cav 
channels as a novel molecular target for insecticides.  
 
Apart from their insecticidal properties, spider venom can cause serious 
envenomation and death in vertebrates and invertebrates. Male M. bradleyi 
spiders are clinically important, but the toxin primarily responsible for the 
envenomation syndrome in humans has not previously been identified. By 
separating whole male M. bradleyi venom and testing for activity, a 42-residue 
peptide (-AOTX-Mb1a) was isolated. In a chick biventer cervicis nerve-
muscle preparation, 85 nM concentration of -AOTX-Mb1a caused an 
increase in resting tension, muscle fasciculation and a decrease in indirect 
twitch tension. These effects were neutralised by A. robustus antivenom. The 
toxic effects were attributed to inhibition of peak tetrodotoxin-sensitive sodium 
current, a slowing of sodium current inactivation and a hyperpolarising shift in 
the voltage at half-maximal activation as determined by whole-cell patch-
clamp analysis on rat dorsal root ganglion neurons. In acute insect toxicity 
bioassays, -AOTX-Mb1a displayed only moderate insecticidal activity in 
house crickets (Acheta domesticus), with doses up to 2 nmol/g causing 
reversible neurotoxic symptoms including involuntary spasms and slight loss 
of coordination within 24 hours. At this dose, lethality was only observed in 
60% of crickets after 48 hours. -AOTX-Mb1a is highly toxic to vertebrates 
through its action on sodium channels, but has relatively low biological activity 




Spider peptide toxins that display non-selective toxicity toward both 
vertebrates and invertebrates can be used as molecular tools to probe the 
function of, and phylogenetic differences in, receptors and ion channels. 
Accordingly, -CNTX-Cs1a, a 74-residue peptide toxin from the venom of the 
Central American hunting spider (Cupiennius salei) that displays high toxicity 
in mammalian and insect bioassays, was investigated. Whole-cell patch-clamp 
experiments showed that -CNTX-Cs1a caused a voltage-independent block 
of mammalian L-type HVA Cav channels in rat neurons and neuroendocrine 
GH3 and GH4 cells, but had no significant effect on other types of HVA, or 
LVA Cav channels. In contrast, -CNTX-Cs1a induced a slow voltage-
independent, concentration-dependent block of both M-LVA and HVA Cav 
channels in whole-cell patch-clamp experiments performed on cockroach 
DUM neurons. -CNTX-Cs1a shows high selectivity for a subset of 
mammalian Cav channels, but indiscriminate activity on invertebrate Cav 
channels, which makes this toxin useful as a molecular tool for further 
investigation of mammalian and insect Cav channels. 
 
The incredible diversity in the phylogenetic selectivity and ion channel 
specificity of spider neurotoxins means there is great potential for these toxins 
as molecular tools, and many may become the defining pharmacology for 
receptor or ion channel subtypes. As a result of such investigations we now 
also understand the underlying basis for clinical envenomation syndromes that 
develop following envenoming, and many are being investigated as 






I would like to sincerely thank Professor Graham Nicholson for his guidance 
and support throughout these past (many) years and for being a great, cool 
supervisor. I‟d also like to thank Assoc Prof Kevin Broady for his witty words of 
wisdom and the crew of the Neurotoxin Research Group (Ben Blacklow, Fran 
Marcon, Monique Windley and Michelle Little) for being there through the 
good times, the bad, sharing a laugh and understanding the pain and anguish 
that is HPLC and patch-clamping. I‟d like to give special mention to Dr Simon 
Gunning and Mr Philip Lawrence for their help with my project and friendship 















PUBLICATIONS ARISING FROM THIS THESIS 
 
1) Herzig, V., Khalife, A.A., Chong, Y., Isbister, G. K., Currie, B.J., Churchill, 
T.B., Horner, S., Escoubas, P., Nicholson, G.M. and Hodgson, W.C. 2008. 
Intersexual variations in Northern (Missulena pruinosa) and Eastern (M. 
bradleyi) mouse spider venom. Toxicon, 517, 1167-77. 
 
2) Chong, Y., Hayes, J.L., Sollod, B., Wen, S., Wilson, D.T., Hains, P.G., 
Hodgson, W.C., Broady, K.W., King, G.F., Nicholson, G.M. 2007. The -
atracotoxins: selective blockers of insect M-LVA and HVA calcium 
channels. Biochemical Pharmacology, 74, 623-38. 
 
3) Kubista, H., Mafra, R.A., Chong, Y., Nicholson, G.M., Beirão, P.S., Cruz, 
J.S., Boehm, S., Nentwig, W., & Kuhn-Nentwig, L. 2007. CSTX-1, a toxin 
from the venom of the hunting spider Cupiennius salei, is a selective 
blocker of L-type calcium channels in mammalian neurons. 
Neuropharmacology, 52, 1650–62. 
 
4) Gunning, S.J., Chong, Y., Khalife, A.A., Hains, P.G., Broady, K.W., 
Nicholson, G.M. 2003. Isolation of -missulenatoxin-Mb1a, the major 
vertebrate-active spider -toxin from the venom of Missulena bradleyi 
















PUBLICATIONS ARISING FROM THIS THESIS……………………………….v 
LIST OF TABLES…………………………………………………………………..ix 
LIST OF FIGURES…………………………………………………………………..x 
LIST OF ABBREVIATIONS AND ACRONYMS……………………………….xiii 
1 INTRODUCTION ...................................................................................... 1 
1.1 THE GLOBAL NEED FOR INSECTICIDES ........................................................... 1 
1.1.1 Insects and Food Security .................................................................................... 1 
1.1.2 Insects and Health ................................................................................................ 2 
1.2 A BRIEF HISTORY OF INSECTICIDES ............................................................... 5 
1.3 MODERN INSECTICIDES ................................................................................. 6 
1.3.1 Chemical Insecticides ........................................................................................... 7 
1.3.2 Insecticide Resistance .......................................................................................... 8 
1.4 BIOPESTICIDES ........................................................................................... 10 
1.4.1 Bacillus thuringiensis (Bt) ................................................................................... 10 
1.4.2 Recombinant Baculoviruses ............................................................................... 12 
1.5 TOXINS IN SPIDER VENOM ........................................................................... 15 
1.5.1 Spider Venom ..................................................................................................... 15 
1.5.2 Peptide Neurotoxins as Pharmacological Tools ................................................. 17 
1.5.3 Peptide Neurotoxins as Insecticides .................................................................. 18 
1.6 VENOM OF AUSTRALIAN FUNNEL-WEB SPIDERS ............................................. 20 
1.6.1 Insecticidal toxins: -hexatoxins ........................................................................ 21 
1.6.2 -hexatoxin-Hv1a ............................................................................................... 22 
1.6.3 Pharmacophore of -HXTX-1 ............................................................................ 23 
1.6.4 Ion channel target of -HXTX-1 ......................................................................... 24 
1.6.5 Oral and Topical Activity of -HXTX-Hv1a ......................................................... 25 
1.7 AIMS AND OBJECTIVES OF THIS PROJECT ..................................................... 26 
2 MATERIALS AND METHODS ............................................................... 28 
2.1 SUPPLY OF SPIDER TOXINS .......................................................................... 28 
2.2 SUPPLY OF EASTERN MOUSE AND SYDNEY FUNNEL-WEB SPIDERS ................. 28 
2.3 SPIDER IDENTIFICATION .............................................................................. 29 
2.3.1 Differentiation of A. robustus and M. bradleyi spiders ............................................ 30 
2.3.2 Identification of male and female M. bradleyi spiders ........................................ 32 
2.3.3  Identification of female A. robustus ................................................................ 34 
2.4 MAINTENANCE OF SPIDERS.......................................................................... 34 
2.5 COLLECTION OF SPIDER VENOM ................................................................... 34 
2.6 FRACTIONATION AND PURIFICATION OF WHOLE VENOM .................................. 36 
2.6.1 Purification of venom fractions and -actinopoditoxin-Mb1a from Missulena 
bradleyi  ............................................................................................................................ 36 
2.6.2 Purification of -hexatoxin-Ar1a toxin from Atrax robustus venom ........................ 37 
2.7 BICINCHONINIC ACID (BCA) PROTEIN ASSAY ................................................. 37 
2.8 INSECT TOXICITY ASSAYS ............................................................................ 38 
2.8.1  Maintenance of crickets ................................................................................. 38 
2.8.2 Insect toxicity test procedures ................................................................................ 38 
2.9 VERTEBRATE TOXICITY ASSAYS ................................................................... 41 
2.10 MASS SPECTROMETRY ................................................................................ 43 
2.11 PYRIDYLETHYLATION OF PURIFIED TOXIN ...................................................... 44 
2.12 N-TERMINAL AMINO ACID SEQUENCING OF TOXIN .......................................... 44 
2.13 INSECT ELECTROPHYSIOLOGICAL EXPERIMENTS ........................................... 44 
vii 
 
2.13.1 Research animals ................................................................................................. 45 
2.13.2 Selection of cockroach neuron for patch-clamp experiments .............................. 45 
2.13.3 Dissection and isolation of DUM neurons ............................................................ 46 
2.13.4 Enzymatic and mechanical separation of dorsal unpaired median neurons ........ 49 
2.13.5 Culturing of DUM neurons .................................................................................... 50 
2.14 MAMMALIAN ELECTROPHYSIOLOGICAL EXPERIMENTS .................................... 51 
2.14.1 Research animals ................................................................................................. 51 
2.14.2 Dissection and isolation of mammalian neurons .................................................. 51 
2.14.3 Enzyme treatment of dorsal root ganglion (DRG) neurons ............................ 52 
2.14.4  Trituration and tissue culture of DRG neurons ............................................... 53 
2.15 ELECTROPHYSIOLOGICAL WHOLE-CELL PATCH-CLAMP SETUP ........................ 57 
2.16 PATCH-CLAMP EXPERIMENTAL PROCEDURE .................................................. 61 
2.16.1 Voltage command protocols for calcium channel currents ................................... 62 
2.16.2 Voltage command protocols for sodium channel currents ................................... 63 
2.16.3 Data analysis ........................................................................................................ 64 
2.17 SYNTHESIS OF -HEXATOXIN-HV1A AND DISELENIDE ANALOGUE ................... 65 
3 ELECTROPHYSIOLOGICAL CHARACTERISATION OF THE INSECT-
SELECTIVE TOXIN, -HEXATOXIN-HV1A, FROM THE VENOM OF THE 
BLUE MOUNTAINS FUNNEL-WEB SPIDER (HADRONYCHE VERSUTA) 68 
3.1 VOLTAGE-GATED CALCIUM CHANNEL CURRENTS IN COCKROACH DUM NEURONS 
  ................................................................................................................. 69 
3.1.1 Use of voltage protocol to elicit Cav channel current subtypes .......................... 71 
3.1.2 Effect of -conotoxin-MVIIC on M-LVA and HVA currents ................................ 73 
3.1.3 Effect of SKF-96365 on M-LVA/HVA calcium currents ...................................... 76 
3.1.4 Effect of inorganic ions on calcium channels in DUM neurons .......................... 77 
3.2 ELECTROPHYSIOLOGICAL CHARACTERISATION OF -HEXATOXIN-HV1A FROM 
BLUE MOUNTAINS FUNNEL WEB SPIDERS (HADRONYCHE VERSUTA)........................... 80 
3.2.1 Block of insect M-LVA and HVA Cav channels by -HXTX-Hv1a ...................... 80 
3.3 EFFECTS OF -HXTX-HV1A ON VOLTAGE-DEPENDENCE OF M-LVA AND HVA 
CHANNEL ACTIVATION ............................................................................................. 83 
3.4 DISELENIDE -HXTX-HV1A TOXIN ............................................................... 84 
4 PURIFICATION AND CHARACTERISATION OF A NOVEL INSECT-
SELECTIVE TOXIN, -HEXATOXIN-AR1A FROM SYDNEY FUNNEL WEB 
(ATRAX ROBUSTUS) ................................................................................... 88 
5 PURIFICATION AND ISOLATION OF AN INSECTICIDAL TOXIN FROM 
THE VENOM OF EASTERN MOUSE SPIDER (MISSULENA BRADLEYI) 105 
5.1 VENOM OF THE EASTERN MOUSE SPIDER: MISSULENA BRADLEYI.................. 105 
5.2 INSECTICIDAL EFFECTS OF M. BRADLEYI VENOM ......................................... 107 
5.3 WHOLE VENOM FRACTIONATION ................................................................ 108 
5.4 INSECT TOXICITY SCREENING OF VENOM FRACTIONS ................................... 109 
5.5 PURIFICATION OF F1 ................................................................................. 112 
5.6 TESTING OF F1.1 AND F1.2 FOR INSECT ACTIVITY ........................................ 113 
5.7 PURIFICATION OF F1.1 AND F1.2 ................................................................ 114 
5.8 PURIFICATION OF F1.2 .............................................................................. 116 
5.9 PURIFICATION OF F4, F5 AND F6 ................................................................ 117 
5.9.1 Attempted separation of f4 ............................................................................... 117 
5.9.2 Attempted separation of f5 and f6 .................................................................... 120 
5.10 SUMMARY AND CONCLUSION ..................................................................... 123 
6 CHARACTERISATION OF THE INSECTICIDAL -ACTINOPODITOXIN-
MB1A FROM EASTERN MOUSE (MISSULENA BRADLEYI) SPIDER 
VENOM ........................................................................................................ 124 
6.1 BACKGROUND AND OVERVIEW .................................................................. 125 
6.2 WHOLE VENOM FRACTION AND PURIFICATION OF F1.2.1 .............................. 126 
viii 
 
6.3 MASS SPECTROMETRY OF F1.2.1 ............................................................... 127 
6.4 BIOLOGICAL ACTIVITIES OF F1.2.1 .............................................................. 128 
6.5 PYRIDYLETHYLATION OF F1.2.1 ................................................................. 130 
6.6 AMINO ACID SEQUENCING OF F1.2.1 TOXIN ................................................. 133 
6.7 MOLECULAR TARGET IDENTIFICATION OF -AOTX-MB1A ............................ 136 
6.7.1 Block of insect M-LVA and HVA Cav channels by -AOTX-Mb1a ................... 136 
6.7.2 Effects of -AOTX-Mb1a on the voltage dependence of M-LVA and HVA Cav 
channel activation .......................................................................................................... 139 
6.8 EFFECTS OF -AOTX-MB1A ON OTHER VOLTAGE-ACTIVATED ION CHANNELS ..... 
  ............................................................................................................... 140 
7 PURIFICATION AND TOXICITY CHARACTERISATION OF -
ACTINOPODITOXIN-MB1A FROM MALE EASTERN MOUSE (MISSULENA 
BRADLEYI) SPIDER VENOM ..................................................................... 143 
7.1 VERTEBRATE TOXICITY ASSAYS OF PEAKS C AND D ..................................... 152 
8 ELECTROPHYSIOLOGICAL CHARACTERISATION OF -
CTENITOXIN-CS1A FROM CUPIENNIUS SALEI ON COCKROACH DUM 
NEURONS ................................................................................................... 154 
9 CONCLUSION ...................................................................................... 168 





LIST OF TABLES 
 
Table 1.1: Examples of vector-borne diseases in humans and/or animals. 3 
Table 1.2: Major chemical classes of insecticides and their market share. 8 
Table 2.1: Composition of insect saline for insect toxicity testing of venom 
fractions. 39 
Table 2.2: Categorisation of signs of toxicity in crickets. 40 
Table 2.3: Composition of organ bath for vertebrate toxicity testing. 42 
Table 2.4: Composition of modified normal insect saline culture media for 
dissected terminal abdominal ganglia (TAG) of P. americana cockroach.
 48 
Table 2.5: Composition of normal iniisect saline culture media for dorsal 
median unpaired (DUM) neurons obtained from terminal abdominal 
ganglia (TAG) of P. americana cockroach. 50 
Table 2.6: Composition of external and internal solutions for recording Cav 
currents from cockroach DUM neurons. 55 
Table 2.7: Composition of external and internal solutions for recording Nav 
currents from cockroach DUM neurons. 56 
Table 2.8: Composition of external and internal solutions for recording Cav 
currents from rat DRG neurons. 57 
Table 5.1: Acute effects of crude female M. bradleyi venom fractions tested in 
House crickets (Acheta domesticus) at 10 g/g. 111 
Table 5.2: Acute effects of crude f1.1 and f1.2 fractions on house crickets 
(Acheta domesticus) after injection at 10 g/g bodyweight. 114 
Table 5.3:Summary of rp-HPLC protocols used in attempts to purify f1.1. 115 
Table 5.4: Summary of rp-HPLC and anion exchange methods used in the 
attempt to purify f4. Anion exchange chromatography was performed 
using a Mono-Q column (Pharmacia Biotech, Sweden), unless otherwise 
specified. 119 




LIST OF FIGURES 
 
Figure 2.1: Female Atrax and Missulena spiders. 30 
Figure 2.2: Shape of Atrax and Missulena caput. 31 
Figure 2.3: Spinnerets of Atrax and Missulena. 31 
Figure 2.4: Male Missulena spiders.  32 
Figure 2.5: Ventral view of female Missulena bradleyi. 33 
Figure 2.6: Collection of venom from female M. bradleyi. 35 
Figure 2.7: Lateroventral cricket injections of toxin solution.  39 
Figure 2.8: Apparatus used for insect toxicity testing. 40 
Figure 2.9: Organ bath and recording equipment. 43 
Figure 2.10: Light micrograph of an isolated dorsal unpaired median (DUM) 
neuron. 46 
Figure 2.11:  Dissection of terminal abdominal ganglia (TAG) from cockroach.
 47 
Figure 2.12: Close up view of excised TAG. 48 
Figure 2.13: Patch-clamp perfusion bath. 58 
Figure 2.14: View of electrode and headstage. 59 
Figure 2.15: Electrophysiology apparatus. 60 
Figure 2.16: Representation of micropipette electrode forming gigaseal on cell.
 61 
Figure 2.17: Voltage command protocols used for recording Cav channel 
currents in cockroach DUM neurons. 63 
Figure 2.18: Voltage command protocols used for recording Nav channel 
currents in cockroach DUM neurons. 64 
Figure 3.1: Voltage-dependent activation of Cav channels in cockroach DUM 
neurons. 72 
Figure 3.2: Typical Ba2+ currents (IBa) recorded from Cav channels in 
cockroach DUM neurons. 73 
Figure 3.3: Effect of CdCl2 on Cav channels in cockroach DUM neurons. 73 
Figure 3.4: Effects of -conotoxin-MVIIC on Cav channels in cockroach DUM 
neurons. 75 
Figure 3.5: Effects of SKF-96365 on Cav channels in cockroach DUM 
neurons. 77 
Figure 3.6: Voltage-independent block of peak IBa after addition of 500 M 
NiCl2. 78 
Figure 3.7: Effects of on NiCl2 on Cav channels in cockroach DUM neurons. 79 
Figure 3.8: Effects of -HXTX-Hv1a low-voltage-activated (LVA) Cav channel 
currents in cockroach DUM neurons. 81 
xi 
 
Figure 3.9: Effects of -HXTX-Hv1a on high-voltage-activated (HVA) Cav 
channel currents in cockroach DUM neurons. 82 
Figure 3.10: On- and off-rates for -HXTX-Hv1a. 83 
Figure 3.11: Effects of -HXTX-Hv1a on Voltage-dependence of Cav channel 
activation. 84 
Figure 3.12: Oral toxicity test of Sec1,4 diselenide bridged -HXTX-Hv1 toxin in 
blowfly (L. cuprina). 86 
Figure 3.13: Effects of Sec1,4 diselenide -HXTX-Hv1a on M-LVA and HVA 
Cav channels in cockroach DUM neurons. 87 
Figure 5.1: Distribution of the Australian Eastern mouse spider (M. bradleyi).
 106 
Figure 5.2: Typical C18 rp-HPLC chromatogram of pooled female M. bradleyi 
spider whole venom. 109 
Figure 5.3: House crickets after injection with insect saline solution containing 
f1. 110 
Figure 5.4: Reverse-phase HPLC chromatogram of f1. 112 
Figure 5.5: Anion exchange FPLC separation of f1. 113 
Figure 5.6: Typical analytical C18 rp-HPLC chromatograms of f1.1 purification. 
 115 
Figure 5.7: Typical rp-HPLC chromatogram of f1.2. 116 
Figure 5.8: Typical analytical C18 rp-HPLC chromatograms of f4. 118 
Figure 5.9: Typical anion exchange FPLC chromatograms of f4.  119 
Figure 5.10: Typical analytical C18 rp-HPLC chromatogram of pooled f5/6. 121 
Figure 5.11: Typical anion exchange FPLC and analytical C18 rp-HPLC 
chromatograms of f5/6. 122 
Figure 6.1: Typical rp-HPLC and anion exchange chromatograms of f1.2.1 
purification.  127 
Figure 6.2: Determination of molecular mass of peptide f1.2.1. 127 
Figure 6.3: Acute toxicity of f1.2.1 in house crickets. 129 
Figure 6.4: The effect of f1.2.1 toxin on the isolated chick biventer cervicis 
nerve-muscle preparation. 129 
Figure 6.5: Reverse-phase analytical C18 HPLC separation of pyridylethylated 
f1.2.1 toxin. 131 
Figure 6.6: ESI-MS of pyridylethylated f1.2.1 toxin. 132 
Figure 6.7: Comparison of the primary structure of -AOTX-Mb1a with known 
members of the -HXTX-1 family of toxins. 135 
Figure 6.8: Effects of -AOTX-Mb1a on M-LVA Cav channels in cockroach 
DUM neurons. 137 




Figure 6.10: Voltage-dependence of Cav channel activation. 140 
Figure 6.11: Effects of -AOTX-Mb1a on Nav channels in cockroach DUM 
neurons. 141 
Figure 7.1: Effects of male M.bradleyi venom peak c and d on isolated chick 




LIST OF ABBREVIATIONS AND ACRONYMS 
 








APAF: Australian Proteome Analysis Facility 
Arg: arginine 
Asn: asparagine 
Asp: aspartic acid 
ATP: adenosine triphosphate 
BCA: bicinchoninic acid 
BSA: bovine serum albumin 
Bt: Bacillus thuringiensis 
Cav: voltage-activated calcium  
cDNA: complementary deoxyribonucleic acid 




DMEM: Dulbecco‟s Modified Eagle Medium 
DNA: deoxyribonucleic acid 
DRG: dorsal root ganglion 
DTT: dithiothreitol 
DUM: dorsal unpaired median 
E. coli: Escherichia coli 
EDTA: ethylenediaminetetraacetic acid 
EGTA: ethylene glycol tetraacetic acid 
ESI-MS: electrospray ionisation mass spectrometry 
FPLC: fast-perfusion liquid chromatography 




Glu: glutamic acid 
Gmax: maximum conductance 
GNA: Galanthus nivalis agglutinin 
GSSG: glutathione disulfide 
GST: glutathione S-transferase  
HEK: human embryonic kidney 
HEPES: 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid sodium salt 
HF: hydrogen fluoride 
HVA: high voltage-activated 
HXTX : hexatoxin 
I: current 
IBa: barium currents 
IC50: half maximal inhibitory concentration 
ICK: inhibitory cystine knot 
KD50: median knockdown dose 
Kv: voltage-activated potassium 
LD50: median lethal dose 
LJP: liquid junction potential 
Lys: lysine 
m/z: mass/charge 
MALDI-TOF MS: matrix-assisted laser desorption/ionisation-time of flight 
mass spectrometry 
MeOH: methanol 
mLVA: maintained low voltage-activated 
M-LVA: mid-low voltage-activated 
Nav: voltage-activated sodium 
NIS: normal insect saline 
POPs: persistent organic pollutants 
Pro: proline 
RNSH: Royal North Shore Hospital 
Rp-HPLC: reverse phase high pressure liquid chromatography 
S: slope factor 
SAR: structure-activity relationship 
Sec: selenocysteine 
Ser: serine 
TAG: terminal abdominal ganglion/ganglia 
xv 
 
TEA-Br: tetraethylammonium bromide 
TEA-Cl: tetraethylammonium chloride 
TEA-OH: tetraethylammonium hydroxide 
TFA: trifluoroacetic acid 
Thr: threonine 




UNSW: University of New South Wales 
USEPA: United States Environmental Protection Agency 




V1/2: voltage of half-maximal activation 
Vh: membrane holding potential 
Vrev: reversal voltage  
WHO: World Health Organisation 
